Cell Metabonomics and its Applications

Abstract

Abstract: Cell metabonomics is often defined as the set of small molecule metabolites in intracellular and membrane. Metabolites are involved in a diverse range of intracellular processes, and their concentrations closely reflect the phenotype of an organism, tissue, or cell. Cell metabonomics is an emerging filed, and it can solve fundamental biological questions and is used to observe metabolic phenomena in cells. In the postgenomics era, cell metabonomics has many potential advantages compared with currently used methods, and it has become a promising analytical tools. This paper briefly reviewed the major research process of cell metabonomics and the progress in application and the integration with other omics.

Key words: cell metabonomics, research process, integration with other omics

CLC Number:

R966

YAO Wei-feng, ZHOU Li-na, ZHANG Li, DING An-wei, LI Wei. Cell Metabonomics and its Applications[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(3): 334-340.

References

[1] Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J]. Xenobiotica, 1999, 29(11): 1181-1189.
[2] Cortés M, Pareja E, Castell JV, et al. Exploring mass spectrometry suitability to examine human liver graft metabonomic profiles[J]. Transplant Proc, 2010, 42(8): 2953-2958.
[3] García-Cañaveras JC, Donato MT, Castell JV, et al. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations[J]. J Proteome Res, 2011, 10(10): 4825-4834.
[4] Fiehn O. Metabolomics the link between genotypes and phenotypes[J]. Plant Mol Biol, 2002, 48: (1/2):155-171.
[5] Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes[J]. Nat Med, 2011, 17(4): 448-453.
[6] Wang X, Zhang A, Han Y, et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease[J]. Mol Cell Proteomics, 2012, 11(8): 370-380.
[7] Cuperlovic-Culf M, Barnett DA, Culf AS, et al. Cell culture metabolomics: applications and future directions[J]. Drug Discov Today, 2010, 15(15/16): 610-621.
[8] Chen R, Mias GI, Li-Pook-Than J, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes[J]. Cell, 2012, 148(6): 1293-1307.
[9] West PR, Weir AM, Smith AM, et al. Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics[J]. Toxicol Appl Pharmacol, 2010, 247(1): 18-27.
[10] Bai J, Wang MX, Chowbay B, et al. Metabolic profiling of HepG2 cells incubated with S(-) and R(+) enantiomers of anti-coagulating drug warfarin[J]. Metabolomics, 2011, 7(3): 353-362.
[11] McNamara LE, Sjöström T, Meek RM, et al. Metabolomics: a valuable tool for stem cell monitoring in regenerative medicine[J]. J R Soc Interface, 2012, 9(73): 1713-1724.
[12] Bayet-Robert M, Morvan D, Chollet P, et al. Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses[J]. Breast Cancer Res Treat, 2010, 120(3): 613-626.
[13] Chong WP, Thng SH, Hiu AP, et al. LC-MS-based metabolic characterization of high monoclonal antibody-producing Chinese hamster ovary cells[J]. Biotechnol Bioeng, 2012, 109(12): 3103-3111.
[14] Valdés A, Simó C, Ibáñez C, et al. Effect of dietary polyphenols on K562 leukemia cells: a Foodomics approach[J]. Electrophoresis, 2012, 33(15): 2314-2327.
[15] Van Gulik WM, Canelas AB, Taymaz-Nikerel H, et al. Fast sampling of the cellular metabolome[J]. Methods Mol Biol, 2012, 881: 279-306.
[16] Wittmann C, Kromer JO, Kiefer P, et al. Impact of the cold shock phenomenon on quantification of intracellular metabolites in bacteria[J]. Anal Biochem, 2004, 327(1): 135-139.
[17] Wiendahl C, Brandner JJ, Kuppers C, et al. A microstructure heat exchanger for quenching the metabolism of mammalian cells[J]. Chem Eng Technol, 2007, 30: 322-328.
[18] Sellick CA, Hansen R, Maqsood AR, et al. Effective quenching processes for physiologically valid metabolite profiling of suspension cultured mammalian cells[J]. Anal Chem, 2009, 81(1): 174-183.
[19] Dietmair S, Timmins NE, Gray PP, et al. Towards quantitative metabolomics of mammalian cells: Development of a metabolite extraction protocol[J]. Anal Biochem, 2010, 404(2): 155-164.
[20] Koǐínek M, Sístek V, Mládková J, et al. Quantification of homocysteine-related metabolites and the role of betaine-homocysteine S-methyltransferase in HepG2 cells[J]. Biomed Chromatogr, 2013, 27(1): 111-121.
[21] Álvarez-Sánchez B, Priego-Capote F, Luque de Castro MD. Metabolomics analysis II. Preparation of biological samples prior to detection[J]. TrAC Trends in Analytical Chemistry, 2010, 29(2): 120-127.
[22] Chrysanthopoulos PK, Goudar CT, Klapa MI. Metabolomics for high-resolution monitoring of the cellular physiological state in cell culture engineering[J]. Metab Eng, 2010, 12(3): 212-222.
[23] Sellick CA, Knight D, Croxford AS, et al. Evaluation of extraction processes for intracellular metabolite profiling of mammalian cells: matching extraction approaches to cell type and metabolite targets[J]. Metabolomics, 2010, 6: 427-438.
[24] Danielsson AP, Moritz T, Mulder H, et al. Development and optimization of a metabolomic method for analysis of adherent cell cultures[J]. Anal Biochem, 2010, 404(1): 30-39.
[25] Lorenz MA, Burant CF, Kennedy RT. Reducing time and increasing sensitivity in sample preparation for adherent mammalian cell metabolomics[J]. Anal Chem, 2011, 83(9): 3406-3414.
[26] Haynes CA, Allegood JC, Sims K, et al. Quantitation of fatty acyl-coenzyme As in mammalian cells by liquid chromatography-electrospray ionization tandem mass spectrometry[J]. J Lipid Res, 2008, 49(5): 1113-1125.
[27] Cao B, Aa J, Wang G, et al. GC-TOFMS analysis of metabolites in adherent MDCK cells and a novel strategy for identifying intracellular metabolic markers for use as cell amount indicators in data normalization[J]. Anal Bioanal Chem, 2011, 400(9): 2983-2993.
[28] Sheikh KD, Khanna S, Byers SW, et al. Small molecule metabolite extraction strategy for improving LC/MS detection of cancer cell metabolome[J]. J Biomol Tech, 2011, 22(1): 1-4.
[29] Faijes M, Mars AE, Smid EJ. Comparison of quenching and extraction methodologies for metabolome analysis of Lactobacillus plantarum[J]. Microb Cell Fact, 2007, 6: 27.
[30] Rooney OM, Troke J, Nicholson JK, et al. High - resolution diffusion and relaxation- edited magic angle spinning 1H NMR spectroscopy of intact liver tissue[J]. Magn Reson Med, 2003, 50(5): 925-930.
[31] Ippolito JE, Merritt ME, Backehed F, et al. Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers[J]. Proc Natl Acad Sci USA, 2006, 103(33): 12505-12510.
[32] Ketola RA, Mauriala T. Mass spectrometric tools for cell and tissue studies[J]. Eur J Pharm Sci, 2012, 46(5): 293-314.
[33] Ruiz-Aracama A, Peijnenburg A, Kleinjans J, et al. An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzop-dioxin[J]. BMC Genomics, 2011, 12: 251.
[34] Suh JH, Kim RY, Lee DS. A new metabolomic assay to examine inflammation and redox pathways following LPS challenge[J]. J Inflamm (Lond), 2012, 9(1): 37.
[35] Fan TW, Lane AN. NMR-based stable isotope resolved metabolomics in systems biochemistry[J]. J Biomol NMR, 2011, 49(3/4): 267-280.
[36] Patterson AD, Li H, Eichler GS, et al. UPLC-ESI-TOFMS-Based Metabolomics and Gene Expression Dynamics Inspector Self-Organizing Metabolomic Maps as Tools for Understanding the Cellular Response to lonizing Radiation[J]. Anal Chem, 2008, 80(3): 665-674.
[37] Kao YY, Liu KT, Huang MF, et al. Analysis of amino acids and biogenic amines in breast cancer cells by capillary electrophoresis using polymer solutions containing sodium dodecyl sulfate[J]. J Chromatogr A, 2010, 1217(4): 582-587.
[38] Wang Y, Gao D, Chen Z, et al. Acridone Derivative 8a induces Oxidative Stress-Mediated Apoptosis in CCRF-CEM Leukemia Cells: Application of Metabolomics in Mechanistic Studies of Antitumor Agents[J]. PLOS ONE, 2013, 8(5): e3572.
[39] Martínez-Martín N, Blas-García A, Morales JM, et al. Metabolomics of the effect of AMPK activation by AICAR on human umbilical vein endothelial cells[J]. Int J Mol Med, 2012, 29(1): 88-94.
[40] Zhang L, Wang L, Hu Y, et al. Selective metabolic effects of gold nanorods on normal and cancer cells and their application in anticancer drug screening[J]. Biomaterials, 2013, 34(29): 7117-7126.
[41] MacIntyre DA, Melguizo Sanchís D, Jiménez B, et al. Characterisation of Human Embryonic Stem Cells Conditioning Media by 1H-Nuclear Magnetic Resonance Spectroscopy[J]. PLOS ONE, 2011, 6(2): e16732.
[42] Le A, Lane AN, Hamaker M, et al. Glucose-independent glutamine metabolism via TCAcycling for proliferation and survival in B-cells[J]. Cell Metab, 2012, 15(1): 110-121.
[43] Tomita M, Kami K. Cancer. Systems biology, metabolomics, and cancer metabolism[J]. Science, 2012, 336(6084): 990-991.
[44] Peng S, Yan L, Zhang J, et al. Hepatotoxicity of perfluorooctanoic acid in human hepatocytes using metabonomics[J]. Se Pu, 2012, 30(2): 123-127.
[45] Yanes O, Clark J, Wong DM, et al. Metabolic oxidation regulates embryonic stem cell differentiation[J]. Nat Chem Biol, 2010, 6(6): 411-417.
[46] Lemons JM, Feng XJ, Bennett BD, et al. Quiescent Fibroblasts Exhibit High Metabolic Activity[J]. PLOS Biol, 2010, 8(10): e1000514.
[47] Van Ravenzwaay B, Cunha GC, Leibold E, et al. The use of metabolomics for the discovery of new biomarkers of effect[J]. Toxicol Lett, 2007, 172(1/2): 21-28.
[48] Lindon JC, Holmes E, Bollard ME, et al. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis[J]. Biomarkers, 2004, 9(1): 1-31.
[49] Klawitter J, Shokati T, Moll V, et al. Effects of lovastatin on breast cancer calls: a proteo-metabonomic study[J]. Breast Cancer Res, 2010, 12(2): R16.
[50] Bordbar A, Mo ML, Nakayasu ES, et al. Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation[J]. Mol Syst Biol, 2012, 8: 558.
[51] Jennen D, Ruiz-Aracama A, Magkoufopoulou C, et al. Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells[J]. BMC Syst Biol, 2011, 5: 139.
[52] Peng S, Yan L, Zhang J, et al. An integrated metabonomics and transcriptomics approach to understanding metabolic pathway disturbance induced by perfluorooctanoic acid[J]. J Pharm Biomed Anal, 2013, 86C: 56-64.